|
V.S. Nikiforov
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
|
№13 / 2022
|
|
E.I. Vereshchagin, E.V. Svechnikova, N.O. Artemyeva
Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout
|
№13 / 2022
|
|
A.E. Bagriy, O.A. Prikolota, A.V. Prikolota, E.S. Mikhailichenko, I.A. Golodnikov, O.N. Bagriy, K.A. Kotova
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
|
№11-12 / 2022
|
|
M.G. Pavlova
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
|
№11-12 / 2022
|
|
A.E. Bagriy, E.S. Mikhailichenko, A.V. Prikolota, K.E. Mogilevskaya
Features of the pathogenesis and treatment of diabetes mellitus during the COVID-19 pandemic
|
№11-12 / 2022
|
|
Yu.I. Khruleva, I.I. Amergulov, N.V. Likhodey, A.S. Dzyuba, Yu.P. Sych, M.G. Pavlova
Multiple thyroid carcinoma and other long-term endocrine consequences of chemoradiotherapy for medulloblastoma: a clinical case
|
№7 / 2022
|
|
O.M. Koteshkova (1), O.V. Dukhareva (1), N.A. Demidov (2), M.B. Antsiferov (1)
The use of the last generation insulin analogues for the control of diabetes mellitus in real clinical practice
|
№4 / 2022
|
|
M.A. Morzhanaeva (1), E.V. Svechnikova (1, 2), E.V. Shchepkina (3), A.I. Kuznetsov (4)
Application of the diabetes screening questionnaire in patients with psoriasis
|
№4 / 2022
|
|
L.Yu. Morgunov
Type 3 diabetes mellitus: is there a chance to become famous?
|
№4 / 2022
|
|
D.O. Ladygina (1), A.V. Zheleznyakova (2)
Dermatoses in elderly diabetic patients
|
№14 / 2021
|
|
A.F. Verbovoy, Yu.A. Dolgikh
Insulin resistance – a common enemy for endocrinologists and cardiologists
|
№12 / 2021
|
|
M.A. Morzhanaeva (1), E.V. Shchepkina (2)
Analysis of anxiety-depressive states of patients with psoriasis and diabetes mellitus
|
№8 / 2021
|
Русский
